XML 41 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Operations (USD $)
3 Months Ended 9 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
REVENUES        
Lab revenue $ 226,260 $ 519,474 $ 974,066 $ 2,170,888
International service revenue 81,229 5,380 84,543 115,524
Learning Center revenue 35,516 22,702 74,555 43,131
License and royalty revenue 5,334 5,415 15,399 21,412
Total Revenues 348,339 552,971 1,148,563 2,350,955
COST OF SALES 164,210 334,735 561,747 1,092,742
GROSS PROFIT 184,129 218,236 586,816 1,258,213
OPERATING EXPENSES        
Salaries and wages 155,583 209,407 450,766 708,229
Depreciation and amortization 4,678 4,679 14,036 14,036
General and administrative expenses 220,996 223,574 744,002 680,245
Total Operating Expenses 381,257 437,660 1,208,804 1,402,510
OPERATING LOSS (197,128) (219,424) (621,988) (144,297)
OTHER INCOME AND EXPENSES        
Change in fair value of derivatives    154,812    (50,459)
Interest income       12   
Interest expense (41,657) (68,271) (107,143) (120,207)
Other income    2,089    5,766
Other expense            
Total Other Income and (Expenses) (41,657) 88,630 (107,131) (164,900)
LOSS FROM CONTINUING OPERATIONS (238,785) (130,794) (729,119) (309,197)
LOSS FROM DISCONTINUED OPERATIONS (1,177) (15,232) (30,368) (93,020)
NET INCOME/(LOSS) (239,962) (146,026) (759,487) (402,217)
NET COMPREHENSIVE INCOME/(LOSS) (239,962) (146,026) (759,487) (402,217)
Deemed Dividend            
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS $ (239,962) $ (146,026) $ (759,487) $ (402,217)
Basic and diluted net income (loss) per common share:        
Basic and diluted loss per share from continuing operations $ 0 $ 0 $ 0 $ 0
Basic and diluted loss per share from discontinued operations $ 0 $ 0 $ 0 $ 0
Basic and diluted net loss per share $ 0 $ 0 $ 0 $ (0.01)
Weighted Average Number of Shares Outstanding, Basic and Diluted 52,504,350 48,210,662 51,434,182 46,784,238